-
-
-
-
-
-
-
Onxeo Reports Half-Year 2019 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Onxeo Divests Two Non-Core Products in Oral Pathologies to Vectans Pharma
-
-
-
-
-
-
-
Onxeo Reports First-Half 2016 Business Update and Consolidated Financials
-
-
-
-
-
-
-
Onxeo: Ordinary and Extraordinary General Meeting on April 6, 2016
-
-
-
-
-
-
1,180,714 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

